Michael Morris, MD
Adult Reconstructive Orthopaedic Surgery · New Albany, OHNPI 1497899223
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $244,550 of the $252,417 with a category attached, or 96.9%. Total Joint Orthopedics, Inc. accounts for 98.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $50,521 and has fallen 99.2% since, to $388 in 2025.
Across 50 payments — averaging $5048.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Total Joint Orthopedics, Inc.$248K
- Zimmer Biomet$4K
- Davol Inc.$37
- Johnson & Johnson$33
- Omnilife Science, Inc$31
- Stryker$29
- plus $74 from 4 others
Across 7 payments — averaging $42,299 each. An ownership or investment interest held by the physician or an immediate family member.
- SPR Therapeutics, Inc$296K
What the payments were for
- Royalty or licence$244,55097%
- Consulting fees$2,0001%
- Travel & lodging$1,6231%
- Food & beverage$7270%
- Education$3,2801%
- Gifts$2370%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Total Joint Orthopedics, Inc. | 34 | $248,358 |
| Zimmer Biomet | 8 | $3,856 |
| Davol Inc. | 1 | $37 |
| Johnson & Johnson | 1 | $33 |
| Omnilife Science, Inc | 1 | $31 |
| Stryker | 1 | $29 |
| Curium US LLC | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $22 |
| DJO, LLC | 1 | $16 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oxford$3,718
How this compares
$252,417 in reported general payments places this provider in the 85th percentile of 59 adult reconstructive orthopaedic surgery providers in Ohio.
See all adult reconstructive orthopaedic surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 89 | $4,183 |
| Meloxicam | 131 | $306 |
| Methylprednisolone | 49 | $223 |
| Oxycodone Hcl | 20 | $131 |
| Tramadol Hcl | 37 | $125 |
| Cephalexin | 17 | $101 |
| Mupirocin | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New Albany
- Adolph LombardiNew Albany$14.7M
- Keith BerendNew Albany$4.6M
- Jason HurstNew Albany$255K
- Ray WasielewskiColumbus$9.6M
- Viktor KrebsCleveland$7.5M
- Nicolas PiuzziCleveland$1.2M
- Michael BloomfieldCleveland$321K
- Matthew BealColumbus$319K
- Trevor MurrayCleveland$192K
- James VoosCleveland$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.